Dairy Biotechnologiessp. z o.o.
Research and experimental development on biotechnology
Overview
milcu offers highly bioavailable curcumin for functional foods and supplements. The product is standardized, stable, and ready for industrial use. The company says it was developed by a Polish team and is fully manufactured in Poland.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2022-11-16. Active
43 1140 2004 0000 3302 8296 1149
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 11, 2023 | Aid for SME access to finance — aid for start-ups | $209.4K$209,419 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
In the case of a one-person management board, declarations of will on behalf of the company are made by the member of the management board independently. In the case of a multi-member management board, two members of the management board acting jointly, or one member of the management board acting jointly with a commercial proxy, are authorised to make declarations of will and sign documents on behalf of the company, provided that, if a member of the management board for financial matters is appointed, in the case of a management board consisting of two or more persons, two members of the management board acting jointly are authorised to make declarations of will and sign documents on behalf of the company, one of whom must be the member of the management board for financial matters.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Maciej Banach (49) | 18 | $243.11 | 8.2569% |
Magdalena Buniowska Olejnik (40) | 18 | $243.11 | 8.2569% |
| 48 | $648.30 | 22.0183% | |
Adam Dariusz Maciejewski (59) | 48 | $648.30 | 22.0183% |
Jakub Urbański (48) | 86 | $1,161.53 | 39.4495% |
Beneficial owners
| Person | Rights |
|---|---|
Jakub Urbański (48)  | Shareholder of a limited liability company, 4300.0 PLN |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Vitagenumsp. z o.o. | $9,376.94 | vitagenum.pl | ||
| 4cell TherapiesS.A. | $9,123.06 | 4celltherapies.com | ||
| Oncotherics PolandS.A. | $7,565.33 | oncotherics.com | ||
| Fusiomicasp. z o.o. | $5,263.98 | fusiomica.com | ||
| Poltisssp. z o.o. | $3,843.72 | poltiss.com | ||
| Omnisepticasp. z o.o. | $3,475.29 | omniseptica.com | ||
| Plan Biosp. z o.o. | $3,404.49 | biotrem.pl | ||
| Greenetoxsp. z o.o. | $3,013.95 | greenetox.com | ||
| Passio Human Microbiomesp. z o.o. | $1,856.58 | passiohumanmicrobiome.com | ||
| Medical Algorithmssp. z o.o. | $682.08 | medicalalgorithms.eu |
Change history
| Date | Event | |
|---|---|---|
| 2023-01-31 | Share capital change (8,500.00 PLN → 10,900.00 PLN) | |
| 2022-09-26 | Entered in the register |
FAQ
Last updated: 2026-06-10